Case number 1:18-cv-00651
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 4, 2023 | 352 | Official Transcript of Trial Transcript held on 03.31.2022 before Judge Colm Connolly. Court Reporter/Transcriber Michele Rolfe,Email: michele_rolfe@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/25/2023. Redacted Transcript Deadline set for 2/6/2023. Release of Transcript Restriction set for 4/4/2023. (Rolfe, Michele) (Entered: 01/04/2023) (311) |
| Jan 4, 2023 | 353 | Official Transcript of Trial Transcript held on 03.30.2022 before Judge Colm Connolly. Court Reporter/Transcriber Michele Rolfe,Email: michele_rolfe@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/25/2023. Redacted Transcript Deadline set for 2/6/2023. Release of Transcript Restriction set for 4/4/2023. (Rolfe, Michele) (Entered: 01/04/2023) (382) |
| Dec 23, 2022 | 351 | NOTICE of Lodging of Surety Bond by Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibits A-B)(Fahnestock, Derek) (Entered: 12/23/2022) (Main Document) (4) |
| Dec 23, 2022 | 351 | NOTICE of Lodging of Surety Bond by Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibits A-B)(Fahnestock, Derek) (Entered: 12/23/2022) (Exhibits A-B) (7) |
| Dec 22, 2022 | 347 | Official Transcript of Bench Trial held on March 28, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/12/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/22/2023. (nmf) (Entered: 12/22/2022) (362) |
| Dec 22, 2022 | 348 | Official Transcript of Bench Trial held on March 29, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/12/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/22/2023. (nmf) (Entered: 12/22/2022) (388) |
| Dec 22, 2022 | 349 | Official Transcript of Bench Trial held on March 30, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Michele Rolfe, Email: michele_rolfe@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/12/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/22/2023. (nmf) (Entered: 12/22/2022) (382) |
| Dec 22, 2022 | 350 | Official Transcript of Bench Trial held on March 31, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Michele Rolfe, Email: michele_rolfe@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/12/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/22/2023. (nmf) (Entered: 12/22/2022) (311) |
| Dec 21, 2022 | 344 | TRANSCRIPT REQUEST by Vanda Pharmaceuticals Inc. for proceedings held on 10/10/20 Markman Hearing, 10/14/20 Markman Hearing and 3/28-31/22 Trial Transcripts before Judge Colm F. Connolly. (Fahnestock, Derek) (Entered: 12/21/2022) (1) |
| Dec 21, 2022 | 345 | Official Transcript of Markman Hearing held on October 10, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Email: Valeriegunning2@comcast.net. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/11/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/21/2023. (nmf) (Entered: 12/21/2022) (123) |
| Dec 21, 2022 | 346 | Official Transcript of Markman Hearing held on October 14, 2020 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Email: Valeriegunning2@comcast.net. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/11/2023. Redacted Transcript Deadline set for 1/23/2023. Release of Transcript Restriction set for 3/21/2023. (nmf) (Entered: 12/21/2022) (25) |
| Dec 19, 2022 | 342 | Official Transcript of Teleconference 1 held on December 13, 2022 before Judge Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/9/2023. Redacted Transcript Deadline set for 1/19/2023. Release of Transcript Restriction set for 3/20/2023. (nmf) (Entered: 12/19/2022) (18) |
| Dec 19, 2022 | 343 | Official Transcript of Teleconference 2 held on December 13, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/9/2023. Redacted Transcript Deadline set for 1/19/2023. Release of Transcript Restriction set for 3/20/2023. (nmf) (Entered: 12/19/2022) (11) |
| Dec 15, 2022 | 341 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 340 Notice of Appeal (Federal Circuit) filed by Vanda Pharmaceuticals Inc. USCA Case Number 2023-1247. (nmf) (Entered: 12/15/2022) (30) |
| Dec 14, 2022 | 340 | Notice of Appeal* (1) |
| Jun 28, 2022 | 329 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Jacob M. Berman as co-counsel. Reason for request: no longer with firm. (Fahnestock, Derek) |
| Jun 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [328] Stipulation Regarding U.S. Patent Nos. 9,060,995, 9,539,234, 9,549,913, 9,855,241, 10,449,176, and 10,610,510, filed by Vanda Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 6/24/2022. (kmd) |
| Jun 23, 2022 | 328 | Stipulation (6) Docket Text: Joint STIPULATION Regarding U.S. Patent Nos. 9,060,995, 9,539,234, 9,549,913, 9,855,241, 10,449,176, and 10,610,510 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 3, 2022 | 327 | Notice (Other) (7) Docket Text: NOTICE of Defendant's Trial Witnesses by Teva Pharmaceuticals USA, Inc. (Keller, Karen) |
| Jun 2, 2022 | 323 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding Vanda's Hyperlinked Post-Trial Briefs and Findings of Fact. (Fahnestock, Derek) |
| Jun 2, 2022 | 324 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding photographs of Vanda's witnesses that testified at trial. (Attachments: # (1) Vanda's Trial Witnesses)(Fahnestock, Derek) |
| Jun 2, 2022 | 324 | Vanda's Trial Witnesses (9) |
| Jun 2, 2022 | 325 | Notice (Other) (3) Docket Text: NOTICE of Lodging the Parties Highlighted Trial Exhibits Cited in Post-Trial Briefing and Findings of Fact by Vanda Pharmaceuticals Inc. (Fahnestock, Derek) |
| Jun 2, 2022 | 326 | Notice of Filing Multi Media Materials (2) Docket Text: NOTICE of filing the following Non-Paper material(s) in multi media format: 1. Defendants' Hyperlinked Opening Post Trial Brief and Proposed Findings of Fact (D.I. Nos. 313 and 314) 2. Defendants' Hyperlinked Responsive Post Trial Brief and Proposed Findings of Fact (D.I. Nos. 315 and 316) 3. Defendants Hyperlinked Reply Post Trial Brief (D.I. No. 322). Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Nathan Roger Hoeschen on behalf of Teva Pharmaceuticals USA, Inc. (Hoeschen, Nathan) |
| Jun 1, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdfs of Defendants' responsive post-trial brief (D.I. [315]) and findings of fact (D.I. [316]) have been replaced to correct several small typographical errors per request of counsel. (nmf) |
| May 31, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdfs of D.I. Nos. [311], [312], [313] and [314] have been replaced with corrected versions to update citations to the final transcripts per request of filer/counsel. (nmf) |
| May 26, 2022 | 321 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF -- Vanda's Reply Post-Trial Brief on Infringement and Objective Indicia of Non-Obviousness -- by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 26, 2022 | 322 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF (Defendants' Reply Brief on Invalidity) by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| May 24, 2022 | 319 | Redacted Document (30) Docket Text: REDACTED VERSION of [315] POST Trial Brief by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| May 24, 2022 | 320 | Redacted Document (30) Docket Text: REDACTED VERSION of [316] Proposed Findings of Fact by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| May 17, 2022 | 317 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF -- Vanda's Responsive Post-Trial Brief on Validity -- by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 17, 2022 | 318 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Apr 26, 2022 | 310 | SO ORDERED (5) Docket Text: SO ORDERED, re [309] Stipulation Regarding U.S. Patent No. 10,829,465, filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 4/26/2022. (kmd) |
| Apr 26, 2022 | 311 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF (Vanda's Opening Post-Trial Brief on Infringement and Objective Indicia of Non-Obviousness) - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Main Document 311 replaced on 5/31/2022) (nmf, ). |
| Apr 26, 2022 | 312 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Main Document 312 replaced on 5/31/2022) (nmf, ). |
| Apr 26, 2022 | 313 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Main Document 313 replaced on 5/31/2022) (nmf, ). |
| Apr 26, 2022 | 314 | Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Main Document 314 replaced on 5/31/2022) (nmf, ). |
| Apr 25, 2022 | 309 | Stipulation (5) Docket Text: Joint STIPULATION and [Proposed] Order Regarding U.S. Patent No. 10,829,465 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Apr 22, 2022 | 308 | Main Document (2) Docket Text: NOTICE of Lodging of Defendants Teva Pharmaceuticals USA, Inc., Apotex Inc., and Apotex Corp. Trial Demonstratives by Teva Pharmaceuticals USA, Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Keller, Karen) |
| Apr 22, 2022 | 308 | Exhibit 1 (68) |
| Apr 22, 2022 | 308 | Exhibit 2 (7) |
| Apr 22, 2022 | 308 | Exhibit 3 (29) |
| Apr 22, 2022 | 308 | Exhibit 4 (50) |
| Apr 22, 2022 | 308 | Exhibit 5 (132) |
| Apr 22, 2022 | 308 | Exhibit 6 (24) |
| Apr 15, 2022 | 307 | Main Document (3) Docket Text: NOTICE of Lodging of List of Agreed Admitted Trial Exhibits - by Vanda Pharmaceuticals Inc. (Attachments: # (1) Admitted Exhibit List)(Fahnestock, Derek) |
| Apr 15, 2022 | 307 | Admitted Exhibit List (13) |
| Apr 14, 2022 | 306 | Main Document (4) Docket Text: NOTICE of Lodging of Vanda's Trial Demonstratives by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibit 1-9)(Fahnestock, Derek) |
| Apr 14, 2022 | 306 | Exhibit 1-9 (295) |
| Apr 11, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Apr 11, 2022 | 305 | SO ORDERED (4) Docket Text: SO ORDERED, re [304] Stipulation Regarding Post-Trial Briefing, filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 4/11/2022. (kmd) |
| Apr 8, 2022 | 304 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Post-Trial Briefing - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Apr 7, 2022 | 303 | Order (4) Docket Text: CLAIM CONSTRUCTION ORDER re [301] PROPOSED ORDER Claim Construction. Signed by Judge Colm F. Connolly on 4/7/2022. (nmf) |
| Apr 6, 2022 | 300 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding manufacturing process. (Jacobs, Karen) |
| Apr 6, 2022 | 301 | Proposed Order (4) Docket Text: PROPOSED ORDER Claim Construction by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Apr 6, 2022 | 302 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding process changes. (Hoeschen, Nathan) |
| Apr 1, 2022 | 298 | Stipulation (5) Docket Text: Joint STIPULATION Narrowing Issues for Trial by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Apr 1, 2022 | 299 | SO ORDERED (5) Docket Text: SO ORDERED, re [298] Stipulation Narrowing Issues for Trial, filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 4/1/2022. (kmd) |
| Mar 31, 2022 | N/A | Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial completed on 3/31/2022. (Court Reporter M. Rolfe.) (kmd) |
| Mar 30, 2022 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 3/30/2022. (Court Reporter M. Rolfe.) (kmd) |
| Mar 30, 2022 | 296 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Karen Jacobs regarding construction of step 1 of claim 1 of the '465 patent. (Jacobs, Karen) |
| Mar 30, 2022 | 297 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding the Court's claim construction hearing on step 1 of claim 1 of the '465 patent. (Hoeschen, Nathan) |
| Mar 29, 2022 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 3/29/2022. (Court Reporter B. Archer.) (kmd) |
| Mar 28, 2022 | N/A | Bench Trial - Begun (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 3/28/2022. (Court Reporter B. Archer.) (kmd) |
| Mar 24, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before March 25, 2022 at 3:00 p.m., the parties shall jointly submit a glossary of terms and names for the court reporter. Ordered by Judge Colm F. Connolly on 3/24/2022. (nmf) |
| Mar 24, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The text of the oral order has been corrected to reflect that the glossary is due to the court reporter on or before March 25, 2022 at 3:00 p.m. (nmf) |
| Mar 16, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has decided upon further consideration that each side shall have no more than 13 hours to try the case. Ordered by Judge Colm F. Connolly on 3/16/2022. (nmf) |
| Mar 14, 2022 | 295 | SO ORDERED (4) Docket Text: SO ORDERED, re [294] Stipulation to dismiss claim 1 of the '487 patent and claims 1 and 5 of the '511 patent, filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 11, 2022 | 294 | Stipulation (4) Docket Text: Joint STIPULATION to dismiss claim 1 of the '487 patent and claims 1 and 5 of the '511 patent by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Mar 10, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Proposed Pretrial Order (D.I. [287] and D.I. [292]) is ADOPTED as modified by the discussion and Court's rulings at the Pretrial Conference. Ordered by Judge Colm F. Connolly on 3/10/2022. (nmf) |
| Mar 9, 2022 | N/A | Pretrial Conference - Final (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Final Pretrial Conference held on 3/9/2022. (Court Reporter Michele Rolfe.) (nmf) |
| Mar 8, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-setting Scheduling Order Deadlines: Due to a conflict in the Court's trial schedule, the Final Pretrial Conference is rescheduled for 3/9/2022 at 05:00 PM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 3/8/2022. (nmf) |
| Mar 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [293] MOTION for Pro Hac Vice Appearance of Attorney Byron L. Pickard, filed by Teva Pharmaceuticals USA, Inc. Ordered by Judge Colm F. Connolly on 3/8/2022. (kmd) |
| Mar 8, 2022 | 293 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Byron L. Pickard - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Mar 7, 2022 | 292 | Exhibit to a Document (3) Docket Text: EXHIBIT re [287] Proposed Pretrial Order (Exhibit 16: Defendants' Updated Statement of Additional Matters) by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Mar 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael F. Milea for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Mar 4, 2022 | 291 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kaan Ekiner on behalf of Apotex Corp., Apotex Inc. (Ekiner, Kaan) |
| Mar 2, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [290] MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue and Derek Gretkowski, filed by Apotex Inc., Apotex Corp. Ordered by Judge Colm F. Connolly on 3/2/2022. (kmd) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kerry B. McTigue,Derek Gretkowski for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Mar 2, 2022 | 290 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue and Derek Gretkowski - filed by Apotex Corp., Apotex Inc.. (Francella, Thomas) |
| Feb 28, 2022 | 289 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. ยง 282 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Feb 22, 2022 | 288 | Redacted Document (30) Docket Text: REDACTED VERSION of [287] Proposed Pretrial Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 9, 2022 | 286 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conference: A Mediation Conference is set for 3/15/2022 at 10:00 AM before Judge Christopher J. Burke. To the extent this order refers to an in-person appearance the parties participation shall be via video conference. Counsel should submit the Confidential Mediation statements by March 8, 2022 and provide the Court with the names of all participants and the appropriate video conferencing link for each side as well as a link for the morning's joint mediation orientation by no later than the due date of the Confidential Mediation Statements. Signed by Judge Christopher J. Burke on 2/9/2022. (dlb) |
| Feb 2, 2022 | 285 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set with Plaintiff and Defendant Teva Pharmaceuticals USA Inc. for 2/7/2022 at 11:00 AM before Judge Christopher J. Burke.. Signed by Judge Christopher J. Burke on 2/2/2022. (dlb). Modified on 2/3/2022 (dlb). |
| Jan 27, 2022 | 284 | SO ORDERED (5) Docket Text: SO ORDERED, re [283] Stipulation Regarding U.S. Patent Nos. 10,071,977, 10,376,487, 10,610,511 and 10,611,744, filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/27/2022. (kmd) |
| Jan 24, 2022 | 283 | Stipulation (5) Docket Text: Joint STIPULATION Regarding U.S. Patent Nos. 10,071,977, 10,376,487, 10,610,511 and 10,611,744 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 19, 2022 | 281 | SO ORDERED (3) Docket Text: SO ORDERED, re [280] STIPULATION for Entry of Consent Judgment and Permanent Injunction as to MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited. Signed by Judge Colm F. Connolly on 1/19/2022. (nmf) |
| Jan 19, 2022 | 282 | Consent Judgment (6) Docket Text: CONSENT JUDGMENT AND PERMANENT INJUNCTION AS TO MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/19/2022. (nmf) |
| Jan 18, 2022 | 280 | Stipulation (9) Docket Text: STIPULATION for Entry of Consent Judgment and Permanent Injunction as to MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 11, 2022 | 279 | SO ORDERED (9) Docket Text: SO ORDERED, re [278] Joint Stipulation and [Proposed] Order Regarding Schedule for Pretrial Exchanges, filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/11/2022. (kmd) |
| Jan 10, 2022 | 278 | Stipulation (9) Docket Text: Joint STIPULATION and [Proposed] Order Regarding Schedule for Pretrial Exchanges by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 17, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael Bruns for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Dec 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [277] MOTION for Pro Hac Vice Appearance of Attorney Michael Bruns, filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 12/7/2021. (kmd) |
| Dec 7, 2021 | 277 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael Bruns - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Nov 23, 2021 | 276 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Eric J. Choi as co-counsel. Reason for request: No longer with the firm Cozen O'Connor. (Francella, Thomas) |
| Nov 15, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Noorossadat Torabi for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Nov 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [275] MOTION for Pro Hac Vice Appearance of Attorney Noorossadat Torabi, Ph.D., filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 11/12/2021. (kmd) |
| Nov 10, 2021 | 275 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Noorossadat Torabi, Ph.D. - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Noorossadat Torabi, Ph.D.)(Bilson, David) |
| Nov 10, 2021 | 275 | Certification of Noorossadat Torabi, Ph.D. (1) |
| Nov 9, 2021 | 274 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove David M. Fry as co-counsel.. (Keller, Karen) |
| Nov 2, 2021 | 273 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Reply Expert Report of Dr. Jonathan Emens Regarding U.S. Patent Nos. 10,376,487, 10,449,176 and 10,610,511; the [HIGHLY CONFIDENTIAL] Reply Expert Report of Dr. Robert B. Perni Regarding Invalidity of U.S. Patent Nos. 10,071,977 and 10,829,4; and the [HIGHLY CONFIDENTIAL] Supplemental Expert Report of DeForest McDuff, Ph.D. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 1, 2021 | 271 | SO ORDERED (3) Docket Text: SO ORDERED, re [270] Joint STIPULATION TO EXTEND TIME of the deadline for reply expert reports from the party with the initial burden of proof on the subject matter to November 1, 2021 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/1/2021. (kmd) |
| Nov 1, 2021 | 272 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Reply Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement of U.S. Patent Nos. 10,071,977 and 10,829,465 By Apotex, (2) Reply Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement of U.S. Patent Nos. 10,071,977 and 10,829,465 By MSN, (3) Reply Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement of U.S. Patent Nos. 10,071,977 and 10,829,465 By Teva, and (4) Reply Report of Daniel Combs, M.D. filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 29, 2021 | 270 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME of the deadline for reply expert reports from the party with the initial burden of proof on the subject matter to November 1, 2021 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Sep 30, 2021 | 269 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Highly Confidential: Rebuttal Expert Report of Dr. Robert B. Perni Regarding Non-Infringement of U.S. Patent Nos. 10,611,744 and 10,829,465 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 29, 2021 | 268 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Supplemental Rebuttal Report of Charles A. Czeisler Ph.D., M.D., F.R.C.P., F.A.P.S., (2) Supplemental Report of Dr. Steven W. Lockley, (3) Supplemental Report of Stephen C. Bergmeier, Ph.D. Regarding the Validity of U.S. Patent No. 10,829,465, and (4) Supplemental Expert Report of Henry G. Grabowski, Ph.D. filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Sep 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [265] MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 9/7/2021. (fms) |
| Sep 7, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Maureen L. Rurka for MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Sep 7, 2021 | 266 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conferences: A Telephone Conference is set for 9/27/2021 at 10:00 AM before Judge Christopher J. Burke with Plaintiff and Defendant Teva Pharmaceuticals USA, Inc. A Telephone Conference is set for 9/27/2021 at 10:15 AM before Judge Christopher J. Burke with Plaintiff and Defendants Apotex Inc. and Apotex Corp. A Telephone Conference is set for 9/27/2021 at 10:30 AM before Judge Christopher J. Burke with Plaintiff and Defendant MSN Pharmaceuticals Inc. Please see Order for details. Signed by Judge Christopher J. Burke on 9/7/2021. (dlb) |
| Sep 7, 2021 | 267 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Kevin E. Warner as co-counsel. Reason for request: No Longer with the Firm. (Bilson, David) |
| Sep 2, 2021 | 265 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Rurka Pro Hac Certification)(Bilson, David) |
| Sep 2, 2021 | 265 | Rurka Pro Hac Certification (1) |
| Aug 27, 2021 | 261 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Opening Expert Report of Dr. Jonathan Emens Regarding U.S. Patent No. 10,610,511 2. Opening Expert Report of Dr. Robert B. Perni Regarding Invalidity of U.S. Patent Nos. 10,611,744 and 10,829,465 filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Aug 27, 2021 | 262 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. Regarding U.S. Patent No. 10,610,511; and (2) Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement By Apotex of U.S. Patent Nos. 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 27, 2021 | 263 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. Regarding U.S. Patent No. 10,610,511; and (2) Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement By MSN of U.S. Patent Nos. 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 27, 2021 | 264 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. Regarding U.S. Patent No. 10,610,511; and (2) Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement By Teva of U.S. Patent Nos. 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 3, 2021 | 259 | SO ORDERED (3) Docket Text: SO ORDERED, re [258] Stipulation filed by Teva Pharmaceuticals USA, Inc.. Signed by Judge Colm F. Connolly on 8/3/2021. (fms) |
| Aug 3, 2021 | 260 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Elizabeth Grden as co-counsel. Reason for request: No long with Winston & Strawn LLP. (Bilson, David) |
| Jul 30, 2021 | 258 | Stipulation (3) Docket Text: STIPULATION (and proposed order) regarding Fact Discovery Deadlines by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jul 29, 2021 | 254 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's First Amended Responses and Objections to Vanda's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 29, 2021 | 255 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Teva's Responses to Vanda's Second Set of Interrogatories to Teva (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465, and 10,611,744 2. Teva's Objections and Responses to Vanda's First Request for Admission to Teva (No. 1) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465, and 10,611,744 3. Teva's Objections and Responses to Vanda's Notice of Deposition of Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 29, 2021 | 256 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's First Request for Admission to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744; and (2) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's Second Set of Interrogatories to Apotex (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Jul 29, 2021 | 257 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses to Vanda's Second Set of Interrogatories to MSN (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744; and MSN's Responses to Vanda's First Request for Admission to MSN (No. 1) Regarding U.S. Patents Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 27, 2021 | 253 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s First Supplemental Objections and Responses to Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Jul 26, 2021 | 252 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objections to Vanda's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John) |
| Jul 20, 2021 | 251 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Responses and Objections to Topics 1-3 and 5-10 of Defendants' Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals Inc. for U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jul 16, 2021 | 250 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's Notice of Deposition of Apotex Inc. and Apotex Corp. filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [249] MOTION for Pro Hac Vice Appearance of Attorney Jacob M. Berman filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 7/15/2021. (nmf) |
| Jul 14, 2021 | 249 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jacob M. Berman - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 13, 2021 | 248 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vandas Responses and Objections to Topic #4 of Defendants Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals Inc. for U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744 and 10,829,465 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Jul 7, 2021 | 245 | Redacted Document (7) Docket Text: REDACTED VERSION of [242] Notice to Take Deposition by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 7, 2021 | 246 | Redacted Document (7) Docket Text: REDACTED VERSION of [243] Notice to Take Deposition by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 7, 2021 | 247 | Redacted Document (7) Docket Text: REDACTED VERSION of [244] Notice to Take Deposition by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 30, 2021 | 241 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Plaintiff Vanda Pharmaceuticals, Inc. on TBD filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jun 29, 2021 | 240 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's First Request for Admission to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744, (2) Vanda's Second Set of Interrogatories to Apotex (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744, (3) Vanda's First Request for Admission to MSN (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744, (4) Vanda's Second Set of Interrogatories to MSN (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744, (5) Vanda's First Request for Admission to Teva (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744, and (6) Vanda's Second Set of Interrogatories to Teva (Nos. 2-5) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 28, 2021 | 239 | SO ORDERED (6) Docket Text: SO ORDERED, re [238] Joint Stipulation Of Amended Schedule filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 6/28/2021. (fms) |
| Jun 24, 2021 | 238 | Stipulation (6) Docket Text: Joint STIPULATION of [Proposed] Amended Schedule by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 11, 2021 | 237 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vandas Objections and Responses to Defendants First Set of Joint Requests for Admission (Nos. 1-5) to Vanda Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744 and 10,829,465; and (2) Vandas Objections and Responses to Defendants First Set of Interrogatories to Vanda (Nos. 1-5) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744 and 10,829,465 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| May 28, 2021 | 236 | Answer to Counterclaim (12) Docket Text: ANSWER to [235] Answer to Amended Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| May 18, 2021 | 235 | Answer to Amended Complaint (28) Docket Text: ANSWER to Amended Complaint, re: [233] Amended Complaint with Affirmative Defenses and, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John) |
| May 12, 2021 | 234 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendants' First Set of Joint Interrogatories to Vanda (Nos. 1-5) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744, and 10,829,465 2. Defendants' First Set of Joint Requests for Admission (Nos. 1-5) to Vanda Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744, and 10,829,465 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| May 5, 2021 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this Lead Civil Action, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) |
| May 5, 2021 | 233 | Main Document (18) Docket Text: First AMENDED COMPLAINT for Patent Infringement against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.- filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits A-B)(Fahnestock, Derek) |
| May 5, 2021 | 233 | Exhibits A-B (42) |
| May 5, 2021 | 233 | Amended Complaint* (1) |
| May 4, 2021 | 232 | SO ORDERED (3) Docket Text: SO ORDERED, re [231] Stipulation and Order Regarding First Amended Complaint filed by Vanda Pharmaceuticals Inc. Plaintiffs shall file the First Amended Complaint in the lead case, No. 18-651-CFC, within five days after entry of this Stipulation by the Court and it shall be deemed served upon filing. Signed by Judge Colm F. Connolly on 5/4/2021. (fms) |
| May 3, 2021 | N/A | Remark (0) Docket Text: The August 25, 2021 Markman hearing is canceled per the entry of the Claim Construction Order at D.I. [230]. (nmf) |
| May 3, 2021 | 230 | Order (5) Docket Text: CLAIM CONSTRUCTION ORDER re [229] PROPOSED ORDER [Proposed] Claim Construction Order filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/3/2021. (nmf) |
| May 3, 2021 | 231 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order Regarding First Amended Complaint by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1 (First Amended Complaint), # (2) Exhibit 2 (Redline))(Fahnestock, Derek) |
| May 3, 2021 | 231 | Exhibit 1 (First Amended Complaint) (61) |
| May 3, 2021 | 231 | Exhibit 2 (Redline) (20) |
| Apr 29, 2021 | 229 | Proposed Order (5) Docket Text: PROPOSED ORDER [Proposed] Claim Construction Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Apr 26, 2021 | 228 | SO ORDERED (5) Docket Text: SO ORDERED, re (21 in 1:21-cv-00121-CFC, 23 in 1:21-cv-00283-CFC, 227 in 1:18-cv-00651-CFC, 20 in 1:21-cv-00282-CFC) Stipulation and Order for Consolidation filed by Vanda Pharmaceuticals Inc. ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CONSOLIDATED ACTION, C.A. NO. 18-651-CFC. Signed by Judge Colm F. Connolly on 4/26/2021. Associated Cases: 1:18-cv-00651-CFC, 1:21-cv-00121-CFC, 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(fms) |
| Apr 21, 2021 | 227 | Stipulation (5) Docket Text: Proposed STIPULATION and Order for Consolidation by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Apr 20, 2021 | 226 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.'s Intrinsic Evidence Supporting Claim Construction for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Apr 16, 2021 | 223 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's Objections and Responses to Vanda's First Interrogatory to Teva (No. 1) Regarding U.S. Patents Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Apr 16, 2021 | 224 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objections to Vanda's First Interrogatory to MSN (No. 1) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Apr 16, 2021 | 225 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Apr 12, 2021 | 221 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Proposed Claim Constructions for Terms in U.S. Patent Nos. 10,610,510, 10,610,511, 10,611,744, and 10,829,465 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Apr 12, 2021 | 222 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Proposed Claims and Constructions for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Apr 6, 2021 | 220 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendants' Initial Invalidity Contentions Concerning U.S. Patent No. 10,829,465 2. Defendants' Invalidity Contentions Concerning U.S. Patent No. 10,611,744 3. Defendants' Invalidity Contentions Regarding U.S. Patent Nos. 10,610,510 and 10,610,511 filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Mar 23, 2021 | 218 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Identification of ESI Custodians filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Mar 23, 2021 | 219 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Identification of ESI Custodians filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Mar 22, 2021 | 216 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Identification of ESI Custodians filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Mar 22, 2021 | 217 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Identification of ESI Custodians filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 17, 2021 | 213 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda's First Interrogatory to Teva (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 17, 2021 | 214 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 17, 2021 | 215 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda's First Interrogatory to MSN (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 15, 2021 | 210 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Teva of U.S. Patent Nos. 10,610,510 and 10,610,511, (2) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Teva of U.S. Patent Nos. 10,829,465 and 10,611,744, and (3) Disclosure of Accused Products and the Asserted Patents and Claims for U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 15, 2021 | 211 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Apotex of U.S. Patent Nos. 10,610,510 and 10,610,511, (2) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by Apotex of U.S. Patent Nos. 10,829,465 and 10,611,744, and (3) Disclosure of Accused Products and the Asserted Patents and Claims for U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 15, 2021 | 212 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by MSN of U.S. Patent Nos. 10,610,510 and 10,610,511, (2) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by MSN of U.S. Patent Nos. 10,829,465 and 10,611,744, and (3) Disclosure of Accused Products and the Asserted Patents and Claims for U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Feb 16, 2021 | 208 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Highly Confidential: Rebuttal Expert Report of Dr. John W. Winkelman Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 2) Highly Confidential: Supplemental Rebuttal Expert Report of Dr. Robert B. Perni Regarding Non-Infringement of U.S. Patent No. 10,071,977 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Feb 16, 2021 | 209 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Supplemental Report of Stephen C. Bergmeier Regarding the Validity of U.S. Patent No. 10,071,977, (2) Rebuttal Report of Andrew Parkinson, Ph.D. Regarding the Validity of U.S. Patent No. 10,376,487, (3) Rebuttal Report of Charles A. Czeisler Ph.D., M.D., F.R.C.P., F.A.P.S., (4) Report of Dr. Stephen W. Lockley, and (5) Expert Report of Henry G. Grabowski, Ph.D. filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Feb 3, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(cak) |
| Feb 3, 2021 | 206 | Scheduling Order (22) Docket Text: SCHEDULING & CONSOLIDATION ORDER: 18-651-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN 18-651-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 8/20/2021. Joint Claim Construction Brief due by 7/23/2021. A Markman Hearing is set for 8/25/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 2/16/2022. A Final Pretrial Conference is set for 3/9/2022 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 3/28/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/3/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Feb 3, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 2/3/2021. (dlb) |
| Jan 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (205 in 1:18-cv-00651-CFC, 21 in 1:20-cv-01334-CFC, 18 in 1:20-cv-01104-CFC, 20 in 1:20-cv-01333-CFC) Stipulation filed by Vanda Pharmaceuticals Inc.. Ordered by Judge Colm F. Connolly on 1/29/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 27, 2021 | 204 | Proposed Order (22) Docket Text: Joint PROPOSED ORDER Joint [Proposed] Scheduling Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 27, 2021 | 205 | Stipulation (5) Docket Text: Joint STIPULATION and [Proposed] Order Regarding Amendment of Expert Report by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (18 in 1:20-cv-01333-CFC, 19 in 1:20-cv-01334-CFC, 203 in 1:18-cv-00651-CFC, 16 in 1:20-cv-01104-CFC) STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 filed by Vanda Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 1/25/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) Modified on 1/25/2021 (nmf). |
| Jan 25, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the stipulation to extend time has been replaced to reflect the correct year. The text of the stipulation as well as the "so ordered" entry have also been updated to change the year to 2021 in the text. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Jan 22, 2021 | 203 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 1/25/2021 (nmf). (Main Document 203 replaced on 1/25/2021) (nmf, ). |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01333-CFC, 202 in 1:18-cv-00651-CFC, 15 in 1:20-cv-01104-CFC, 18 in 1:20-cv-01334-CFC) Stipulation filed by Teva Pharmaceuticals USA, Inc.. Ordered by Judge Colm F. Connolly on 1/19/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 15, 2021 | 202 | Stipulation (3) Docket Text: STIPULATION (and proposed order) to extend time to submit proposed revised scheduling order by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jan 13, 2021 | 201 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Highly Confidential: Supplemental Expert Report of David J. Greenblatt, M.D. Regarding U.S. Patent No. 10,376,487 2) Highly Confidential: Supplemental Expert Report of Dr. Jonathan Emens Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 3) Highly Confidential: Amended Supplemental Invalidity Expert Report of Robert B. Perni Regarding U.S. Patent No. 10,071,977 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jan 11, 2021 | 200 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Supplemental Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement by Apotex of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 23, 2020 | 199 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of David J. Greenblatt, M.D. Regarding U.S. Patent No. 10,376,478 (2) Opening Expert Report of Dr. Jonathan Emens Regarding U.S. Patent Nos. 10,376,487 & 10,449,176 (3) Supplemental Invalidity Expert Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Dec 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [197] Stipulation filed by Apotex Inc., Apotex Corp.. Signed by Judge Colm F. Connolly on 12/21/2020. (fms) |
| Dec 21, 2020 | 198 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. Regarding U.S. Patent Nos. 10,376,487 and 10,449,176, (2) Supplemental Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement by MSN of U.S. Patent No. 10,071,977 and (3) Supplemental Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement by Teva of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 18, 2020 | 197 | Stipulation (3) Docket Text: Joint STIPULATION to Extend Expert Discovery Deadlines by Apotex Corp., Apotex Inc.. (Francella, Thomas) |
| Dec 11, 2020 | 196 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Third Supplemental Responses to Vanda's First Set of Interrogatories to MSN (No. 1) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 20, 2020 | 192 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vandas Objections and Responses to Defendants Second Set of Interrogatories to Vanda (No. 5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Nov 20, 2020 | 193 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Responses to Vanda's Second Set of Interrogatories to Teva (Nos. 3-5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 (2) Teva's Second Supplemental Responses to Vanda's First Set of Interrogatories to Teva (Nos. 1-2) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 20, 2020 | 194 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Objections and Responses to Vanda's Second Set of Interrogatories to MSN (Nos. 4-5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 20, 2020 | 195 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's Second Set of Interrogatories to Apotex (Nos. 4-5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176; and (2) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's First Interrogatory to Apotex (No. 1) Regarding U.S. Patent No. 10,071,977 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Nov 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [191] MOTION for Pro Hac Vice Appearance of Attorney Michael F. Milea filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/19/2020. (fms) |
| Nov 19, 2020 | 191 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael F. Milea - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Nov 16, 2020 | 189 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vandas First Supplemental Objections and Responses to Defendants First Set of Interrogatories to Vanda (Nos. 2 & 4) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Nov 16, 2020 | 190 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Second Supplemental Objections and Responses to Vanda's First Set of Interrogatories to Apotex (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Nov 13, 2020 | 187 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vandas Responses and Objections to Defendants Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals Inc. for U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Nov 13, 2020 | 188 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Second Supplemental Responses to Vanda's First Set of Interrogatories to MSN (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 12, 2020 | 185 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's Objections and Responses to Vanda's Notice of Deposition of Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 12, 2020 | 186 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objections to Vanda's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 11, 2020 | 184 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's Notice of Deposition of Apotex Inc. and Apotex Corp.; and (2) Apotex Inc. and Apotex Corp.'s Objections and Responses to Vanda's Notice of Deposition of Apotex Inc. and Apotex Corp. (Additional '977 Discovery) filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Oct 28, 2020 | 183 | Order (6) Docket Text: CLAIM CONSTRUCTION ORDER re [182] [Proposed] Claim Construction Order filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/28/2020. (nmf) |
| Oct 27, 2020 | 182 | Proposed Order (6) Docket Text: PROPOSED ORDER [Proposed] Claim Construction Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 26, 2020 | 181 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Objections and Responses to Defendants' First Set of Interrogatories to Vanda (Nos. 1-4) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 23, 2020 | 180 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Vanda Pharmaceuticals [Pursuant to Rule 30(b)(6) for U.S. Patent Nos. 10,376,487 and 10,449,176] on TBD filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 21, 2020 | 176 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Interrogatories to Vanda (No. 5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 21, 2020 | 177 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vandas Second Set of Interrogatories to MSN (Nos. 4-5) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176; and (2) Notice of Deposition of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 21, 2020 | 178 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vandas Second Set of Interrogatories to Teva (Nos. 35) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176; and (2) Notice of Deposition of Teva Pharmaceuticals USA, Inc. filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 21, 2020 | 179 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Vandas First Interrogatory to Apotex (No. 1) Regarding U.S. Patent No. 10,071,977; (2) Vandas Second Set of Interrogatories to Apotex (Nos. 45) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176; (3) Notice of Deposition of Apotex Inc. and Apotex Corp.; and (4) Notice of Deposition of Apotex and Apotex Corp. (Additional 977 Discovery) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 14, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 10/14/2020. (Court Reporter V. Gunning.) (nmf) |
| Oct 13, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court is inclined to construe "analyzing the batch for one or more of [Impurities 1-7]" as determining whether the batch contains one or more of Impurities 1-7" and is inclined to construe being treated with tasimelteon" as "already taking tasimelteon." Each party shall each inform the Court by letter no later than 3:00 today whether it would agree to these constructions. Ordered by Judge Colm F. Connolly on 10/13/2020. (nmf) |
| Oct 13, 2020 | N/A | Remark (0) Docket Text: Remark: The 10/14/2020 Markman Hearing is a public hearing and having received a request to listen from a member of the public, the hearing information is: Dial In: 877-434-2295Participant Passcode: 3023519227 (nmf) |
| Oct 13, 2020 | 174 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding Response to the Court's October 13th Oral Order Regarding Claim Construction for U.S. Patent Nos. 10,071,977 and 10,376,487 - re Oral Order,. (Fahnestock, Derek) |
| Oct 13, 2020 | 175 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding the Court's proposed constructions - re Oral Order,. (Hoeschen, Nathan) |
| Sep 29, 2020 | 173 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's First Supplemental Responses to Vanda's First Set of Interrogatories to Teva (Nos. 12) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 28, 2020 | 172 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s First Supplemental Objections and Responses to Vanda's First Set of Interrogatories to Apotex (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Sep 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a conflict in the Court's trial schedule, the Telephonic Markman Hearing is rescheduled for 10/14/2020 at 08:00 AM before Judge Colm F. Connolly. Counsel for Plaintiff shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 9/22/2020. (nmf) |
| Sep 18, 2020 | 171 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Interrogatories to Vanda (Nos. 1-4) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Sep 16, 2020 | 169 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Responses to Vanda's First Set of Interrogatories to Teva (Nos. 12) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 16, 2020 | 170 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.s Objections and Responses to Vandas First Set Of Interrogatories to Apotex (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Sep 11, 2020 | 168 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding Claim Construction. (Fahnestock, Derek) |
| Sep 4, 2020 | 166 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF Regardin U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Sep 4, 2020 | 167 | Main Document (7) Docket Text: Joint APPENDIX re [166] Joint Claim Construction Brief Regarding U.S. Patent No. 10,071,977 by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-3)(Jacobs, Karen) |
| Sep 4, 2020 | 167 | Exhibit 1-3 (46) |
| Sep 1, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the redacted document at D.I. [159] and its attachments have been replaced per request of filer to comply with Judge Connolly's direction during the last teleconference. (nmf) |
| Sep 1, 2020 | 165 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief Regarding U.S. Patent No. 10,071,977 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Aug 25, 2020 | 164 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Reply Claim Construction Brief Regarding U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 19, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 8/19/2020. (Court Reporter V. Gunning.) (nmf) |
| Aug 19, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Hearings: A Markman Hearing is set for 10/14/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. If the Court's trial schedule should change, the Markman Hearing will be held on 9/24/2020 at 9:00 AM. Ordered by Judge Colm F. Connolly on 8/19/2020. (nmf) |
| Aug 18, 2020 | N/A | Remark (0) Docket Text: Remark: The 8/19/2020 Teleconference will be public. The information for the call is: Call In: 888-808-6929 Access: 6789416 (nmf) |
| Aug 18, 2020 | 163 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief Regarding U.S. Patent No. 10,071,977 re [156] MOTION for Claim Construction re [153] Claim Construction Chart , [154] MOTION Defendants' Motion for Claim Construction filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John) |
| Aug 17, 2020 | 159 | Main Document (5) Docket Text: REDACTED VERSION of [152] Letter by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Exhibits A-D)(Phillips, John) (Main Document 159 replaced on 9/1/2020) (nmf, ). (Attachment 1 replaced on 9/1/2020) (nmf, ). |
| Aug 17, 2020 | 159 | Exhibits A-D (12) |
| Aug 17, 2020 | 160 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas First Set of Interrogatories to Apotex (Nos. 13) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Aug 17, 2020 | 161 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas First Set of Interrogatories to MSN (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Aug 17, 2020 | 162 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas First Set of Interrogatories to Teva (Nos. 1-2) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Aug 14, 2020 | 158 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Reply Report of Daniel Combs, M.D. filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Aug 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [157] STIPULATION TO EXTEND TIME of Deadline for Reply Expert Reports on U.S. Patent No. 10,071,977 to March 5, 2021 filed by Vanda Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 8/13/2020. (fms) |
| Aug 13, 2020 | 157 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Deadline for Reply Expert Reports on U.S. Patent No. 10,071,977 to March 5, 2021 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Aug 12, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [152] [SEALED] Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding disputes related to claim construction. ORDER Setting Teleconference: The Markman Hearing is postponed and A Telephone Conference will be held on 8/19/2020 at 09:00 AM before Judge Colm F. Connolly to discuss the issues outlined in Counsel's letter. Counsel shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 8/12/2020. (nmf) |
| Aug 10, 2020 | 153 | Main Document (7) Docket Text: CLAIM Construction Chart by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1 - '977 Patent)(Bilson, David) |
| Aug 10, 2020 | 153 | Exhibit 1 - '977 Patent (12) |
| Aug 10, 2020 | 154 | Motion for Miscellaneous Relief (3) Docket Text: MOTION Defendants' Motion for Claim Construction - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| Aug 10, 2020 | 155 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Opening Claim Construction Brief Regarding U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 10, 2020 | 156 | Motion for Miscellaneous Relief (4) Docket Text: MOTION for Claim Construction re [153] Claim Construction Chart - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Aug 7, 2020 | 150 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF regarding U.S. Patent No. 10,376,487 filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 7, 2020 | 151 | Main Document (4) Docket Text: APPENDIX re [150] Joint Claim Construction Brief by Teva Pharmaceuticals USA, Inc.. (Attachments: # (1) Exhibit 1 - 3)(Hoeschen, Nathan) |
| Aug 7, 2020 | 151 | Exhibit 1 - 3 (103) |
| Jul 30, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman Hearing set for 8/19/2020 at 9:00 a.m. shall be held by telephone. Counsel for the parties shall coordinate the call and email the dial-in information to the court. Ordered by Judge Colm F. Connolly on 7/30/2020. (nmf) |
| Jul 29, 2020 | 149 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Reply Claim Construction Brief Regarding U.S. Patent No. 10,376,487 filed by Vanda Pharmaceuticals Inc.(Fahnestock, Derek) |
| Jul 27, 2020 | 148 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Addendum to Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jul 7, 2020 | 147 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Opening Claim Construction Brief Regarding U.S. Patent No. 10,376,478 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [146] STIPULATION TO EXTEND TIME of certain Markman deadlines to various dates filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 6/29/2020. (fms) |
| Jun 26, 2020 | 146 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME of certain Markman deadlines to various dates - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [142] Joint STIPULATION TO EXTEND TIME to Submit the Joint Claim Construction Chart to June 24, 2020 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 6/24/2020. (fms) |
| Jun 24, 2020 | 143 | Main Document (10) Docket Text: CLAIM Construction Chart by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1 - US10376487 ('487 Patent0, # (2) Exhibit 2 - US10449176 ('176 Patent))(Bilson, David) |
| Jun 24, 2020 | 143 | Exhibit 1 - US10376487 ('487 Patent0 (5) |
| Jun 24, 2020 | 143 | Exhibit 2 - US10449176 ('176 Patent) (37) |
| Jun 24, 2020 | 144 | Motion for Miscellaneous Relief (3) Docket Text: MOTION [Defendants' Motion for Claim Construction] re [143] Claim Construction Chart - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| Jun 24, 2020 | 145 | Motion for Miscellaneous Relief (5) Docket Text: MOTION for Claim Construction for U.S. Patent Nos. 10,376,487 and 10,449,176 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [141] Joint STIPULATION TO EXTEND TIME to submit the Joint Claim Construction Chart to June 23, 2020 filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 6/23/2020. (fms) |
| Jun 23, 2020 | 142 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit the Joint Claim Construction Chart to June 24, 2020 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 22, 2020 | 141 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to submit the Joint Claim Construction Chart to June 23, 2020 - filed by Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Jun 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [140] Joint STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to June 22, 2020 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 6/19/2020. (nmf) |
| Jun 18, 2020 | 140 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to June 22, 2020 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 12, 2020 | 139 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Kira A. Davis as co-counsel.. (Fahnestock, Derek) |
| Jun 5, 2020 | 137 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Proposed Constructions for Claim Term(s)/Phrase(s) Identified by the Parties for U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jun 5, 2020 | 138 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.'s Identification of Claim Terms and Disclosure of Proposed Constructions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| May 22, 2020 | 136 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Invalidity Contentions re: U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| May 20, 2020 | 135 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's Supplemental Corrected Contentions Regarding Infringement by Apotex of U.S. Patent Nos. 10,376,487 and 10,449,176; (2) Vanda's Supplemental Corrected Contentions Regarding Infringement by MSN of U.S. Patent Nos. 10,376,487 and 10,449,176; and (3) Vanda's Supplemental Corrected Contentions Regarding Infringement by Teva of U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| May 13, 2020 | 134 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Corrected Rebuttal Report of Andrew Parkinson, Ph.D. filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| May 8, 2020 | 131 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas Contentions Regarding Infringement by Apotex Inc. and Apotex Corp. of U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| May 8, 2020 | 132 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas Contentions Regarding Infringement by MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited of U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| May 8, 2020 | 133 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vandas Contentions Regarding Infringement by Teva Pharmaceuticals USA, Inc. of U.S. Patent Nos. 10,376,487 and 10,449,176 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 19 in 1:19-cv-00560-CFC, 20 in 1:19-cv-00685-CFC) Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc., (20 in 1:20-cv-00235-CFC, 129 in 1:18-cv-00651-CFC, 25 in 1:19-cv-02202-CFC, 133 in 1:18-cv-00690-CFC, 21 in 1:20-cv-00093-CFC, 132 in 1:18-cv-00689-CFC, 20 in 1:20-cv-00083-CFC, 23 in 1:19-cv-02375-CFC, 18 in 1:20-cv-00318-CFC) Stipulation filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| Apr 21, 2020 | 128 | Stipulation (4) Docket Text: Joint STIPULATION of Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 21, 2020 | 129 | Stipulation (4) Docket Text: Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 21, 2020 | 130 | SO ORDERED (4) Docket Text: SO ORDERED, re (131 in 1:18-cv-00689-CFC, 128 in 1:18-cv-00651-CFC, 132 in 1:18-cv-00690-CFC) Stipulation filed by Vanda Pharmaceuticals Inc., SCHEDULING ORDER: Expert Discovery due by 4/30/2021., A Final Pretrial Conference is set for 6/30/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., A Bench Trial is set for 7/19/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/21/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 16, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before April 23, 2020, the parties shall submit a revised proposed scheduling order incorporating the new hearing dates as discussed during the scheduling teleconference in the related civil actions on April 2, 2020. Ordered by Judge Colm F. Connolly on 4/16/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 2, 2020 | N/A | Remark (0) Docket Text: Remark: Counsel shall submit a proposed revised scheduling order incorporating the new pretrial conference and trial dates given during the scheduling conference in the related civil actions today. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 1, 2020 | 127 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Report of Dr. Charles A. Czeisler, (2) Report of Dr. Steven W. Lockley, (3) Report of Dr. Andrew Parkinson, (4) Report of Dr. Henry G. Grabowski, and (5) Report of Dr. Stephen C. Bergmeier filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Mar 30, 2020 | 126 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Expert Report of Deborah Jaskot 2) Rebuttal Expert Report of Dr. Robert B. Perni Regarding Non-Infringement of U.S. Patent No. 10,071,977 3) First Expert Report of Dr. John W. Winkelman filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Mar 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (128 in 1:18-cv-00689-CFC, 125 in 1:18-cv-00651-CFC, 128 in 1:18-cv-00690-CFC) Joint STIPULATION to Extend Expert Discovery Deadlines. Signed by Judge Colm F. Connolly on 3/27/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Mar 27, 2020 | 125 | Stipulation (3) Docket Text: Joint STIPULATION to Extend Expert Discovery Deadlines by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (127 in 1:18-cv-00689-CFC, 124 in 1:18-cv-00651-CFC, 127 in 1:18-cv-00690-CFC) Joint STIPULATION to Extend Expert Discovery Deadlines. Signed by Judge Colm F. Connolly on 3/18/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Mar 18, 2020 | 124 | Stipulation (4) Docket Text: Joint STIPULATION to Extend Expert Discovery Deadlines by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (123 in 1:18-cv-00651-CFC, 126 in 1:18-cv-00690-CFC, 126 in 1:18-cv-00689-CFC) Stipulation of Proposed Amended Schedule filed by Vanda Pharmaceuticals Inc.. Signed by Judge Colm F. Connolly on 3/3/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Mar 2, 2020 | 123 | Stipulation (4) Docket Text: Joint STIPULATION of Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 4, 2020 | 122 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Invalidity Expert Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 (2) First Expert Report of Dr. Jonathan Emens (4) Opening Expert Report of David J. Greenblatt, M.D. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 31, 2020 | 121 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. and (2) Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement by Teva of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Jan 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (120 in 1:18-cv-00651-CFC, 120 in 1:18-cv-00690-CFC, 123 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME of Certain Deadlines for Expert Discovery to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/24/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Jan 24, 2020 | 120 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME of Certain Deadlines for Expert Discovery to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 15, 2020 | 119 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda's Supplemental Objections and Responses to Teva's First Set of Interrogatories to Plaintiff (No. 8) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 26, 2019 | 118 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda's Amended Objections and Responses to Teva's First Set of Interrogatories to Plaintiff (Nos. 2 and 5-7) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 23, 2019 | 117 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Second Supplemental Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 20, 2019 | 116 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Second Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (No. 3) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 18, 2019 | 115 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (Nos. 1-4, 6-8, and 10) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 10, 2019 | 114 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to Teva; and (2) Vanda's Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to MSN filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 3, 2019 | 113 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Supplemental Invalidity Contentions Concerning U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829; and (3) Defendants' Second Amended Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Dec 2, 2019 | 112 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses to Discovery Requests filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Nov 27, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Responses to Vanda's Second Set of Joint Interrogatories to Defendants (Nos. 9-10) (2) Teva's Responses to Vanda's First Set of Interrogatories to Teva (Nos. 1 & 2) filed by Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Nov 26, 2019 | 110 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Vatsal Shah on December 3, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Nov 13, 2019 | 109 | SO ORDERED (4) Docket Text: SO ORDERED, re (114 in 1:18-cv-00689-CFC, 110 in 1:18-cv-00690-CFC, 108 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/13/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 12, 2019 | 108 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 31, 2019 | 107 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Responses and Objections to Defendants' Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Oct 29, 2019 | 105 | SO ORDERED (8) Docket Text: SO ORDERED, re (106 in 1:18-cv-00690-CFC, 104 in 1:18-cv-00651-CFC, 108 in 1:18-cv-00689-CFC) CLAIM CONSTRUCTION ORDER. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 29, 2019 | 106 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Tevas Objections and Responses to Vandas Notice of Deposition of Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 25, 2019 | 104 | Proposed Order (8) Docket Text: PROPOSED ORDER /Proposed Claim Construction Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 18, 2019 | 103 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Subpoenas to Testify at a Deposition in a Civil Action directed to Marlene Dressman, Louis Licamele, John Feeney III, Stephen F. Swinton Jr., and Natalie M. Platt filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Oct 16, 2019 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva's First Set of Requests for Admission (Nos. 1-15) to Plaintiff (2) Defendant Teva's First Set of Interrogatories to Plaintiff filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 16, 2019 | 102 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Set of Joint Requests for Admission (Nos. 1-20) to Plaintiff (2) Defendants' Second Set of Joint Interrogatories to Plaintiff (3) Defendants' Joint Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 109-146) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 15, 2019 | 95 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Vanda's Second Set of Joint Interrogatories to Defendants (Nos. 9-10), (2) Vanda's First Set of Interrogatories to Teva (Nos. 1 & 2), (3) Vanda's Second Set of Interrogatories to Apotex (Nos. 2 & 3) and (4) Vanda's Second Set of Interrogatories to MSN (Nos. 7 & 8) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 97 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of David DeCicco on November 11, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 98 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Atul Kaushik on November 12, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 99 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bipin Salunkhe on November 14, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 100 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Chirag Shah on November 15, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 14, 2019 | 90 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Rosarelis Torres on November 4, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 91 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jim Kelly on November 6, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 92 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mihael Polymeropoulos on November 5, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 93 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Ravi K. Pandrapragada on November 12, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 94 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Deepak Phadke on November 14, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 10, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 10/10/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (88 in 1:18-cv-00651-CFC, 93 in 1:18-cv-00689-CFC, 91 in 1:18-cv-00690-CFC) MOTION for Pro Hac Vice Appearance of Attorney Sasha Rao filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 10/2/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Oct 2, 2019 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 1, 2019 | 88 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sasha Rao - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 20, 2019 | 87 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Amended Invalidity Contentions filed by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Aug 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (86 in 1:18-cv-00651-CFC, 89 in 1:18-cv-00690-CFC, 91 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to August 30, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 8/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Aug 12, 2019 | 86 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to August 30, 2019 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| Jul 26, 2019 | 82 | Claim Construction Chart (30) Docket Text: CLAIM Construction Chart by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 26, 2019 | 83 | Claim Construction Opening Brief (30) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF /Joint Claim Construction Brief filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 26, 2019 | 84 | Main Document (5) Docket Text: APPENDIX re (83 in 1:18-cv-00651-CFC) Claim Construction Opening Brief, (85 in 1:18-cv-00690-CFC) Claim Construction Opening Brief, (88 in 1:18-cv-00689-CFC) Claim Construction Opening Brief /Appendix of Exhibits by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-3, # (2) Exhibits 4-7, # (3) Exhibit 8, # (4) Exhibits 9-13)(Fahnestock, Derek) |
| Jul 26, 2019 | 84 | Exhibits 1-3 (120) |
| Jul 26, 2019 | 84 | Exhibits 4-7 (133) |
| Jul 26, 2019 | 84 | Exhibit 8 (151) |
| Jul 26, 2019 | 84 | Exhibits 9-13 (106) |
| Jul 26, 2019 | 85 | Motion for Miscellaneous Relief (4) Docket Text: MOTION Claim Construction re (87 in 1:18-cv-00689-CFC, 82 in 1:18-cv-00651-CFC, 84 in 1:18-cv-00690-CFC) Claim Construction Chart /Vanda's Motion on Claim Construction - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 19, 2019 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Regarding U.S. Patent No. 10,149,829 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 12, 2019 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 3, 2019 | 79 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's Objections and Responses to Defendants' Joint First Set of Requests for Production of Documents (Nos. 1-108) and (2) Vanda's Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (Nos. 1-10) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 20, 2019 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Teva's Responses to Vanda's First Set of Joint Interrogatories (Nos. 1-8) to Defendants. 2. Teva's Responses to Vanda's First Set of Joint Requests for Admission to Defendant (No. 1) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 14, 2019 | 77 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Reply Claim Construction Brief filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 12, 2019 | 75 | SO ORDERED (4) Docket Text: SO ORDERED, re (19 in 1:19-cv-00560-CFC, 74 in 1:18-cv-00651-CFC) Stipulation Regarding Consolidation of Cases filed by Vanda Pharmaceuticals Inc. C.A. No. 19-560 (CFC) shall be consolidated with C.A. No. 18-651 (CFC) for all purposes. All filings shall be in C.A. No. 18-651 (CFC). Signed by Judge Colm F. Connolly on 6/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:19-cv-00560-CFC(fms) |
| Jun 12, 2019 | 76 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 10, 2019 | 74 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation of Cases by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 3, 2019 | 73 | SO ORDERED (6) Docket Text: SO ORDERED, re (15 in 1:19-cv-00560-CFC, 10 in 1:19-cv-00926-CFC, 72 in 1:18-cv-00651-CFC, 76 in 1:18-cv-00689-CFC, 73 in 1:18-cv-00690-CFC, 16 in 1:19-cv-00685-CFC) Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829. Signed by Judge Colm F. Connolly on 6/3/2019. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| May 31, 2019 | 72 | Stipulation (6) Docket Text: Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 20, 2019 | 71 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] First Set of Joint Interrogatories to Plaintiff and [CONFIDENTIAL] Joint First Requests for the Production of Documents and Things to Plaintiff (Nos. 1-108) filed by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| May 17, 2019 | 70 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 14, 2019 | 69 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Vanda's First Set of Joint Interrogatories to Defendants (Nos. 1-8) and (2) Vanda's First Set of Joint Requests for Admission to Defendants (No. 1), (3) Vanda's First Set of Interrogatories to Apotex (No. 1) and (4) Vanda's First Set of Interrogatories to MSN (Nos. 1-6) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Apr 12, 2019 | 68 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Opening Claim Construction Brief filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 13, 2019 | 66 | Claim Construction Chart (30) Docket Text: CLAIM Construction Chart by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 13, 2019 | 67 | Main Document (5) Docket Text: APPENDIX re (67 in 1:18-cv-00690-CFC, 66 in 1:18-cv-00651-CFC, 70 in 1:18-cv-00689-CFC) Claim Construction Chart /Appendix of Exhibits to Joint Claim Construction Chart by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-3, # (2) Exhibits 4-5, # (3) Exhibits 6-7, # (4) Exhibit 8, Pt 1, # (5) Exhibit 8, Pt 2, # (6) Exhibits 9-13)(Fahnestock, Derek) |
| Mar 13, 2019 | 67 | Exhibits 1-3 (120) |
| Mar 13, 2019 | 67 | Exhibits 4-5 (79) |
| Mar 13, 2019 | 67 | Exhibits 6-7 (54) |
| Mar 13, 2019 | 67 | Exhibit 8, Pt 1 (79) |
| Mar 13, 2019 | 67 | Exhibit 8, Pt 2 (80) |
| Mar 13, 2019 | 67 | Exhibits 9-13 (117) |
| Mar 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (65 in 1:18-cv-00690-CFC, 65 in 1:18-cv-00651-CFC, 69 in 1:18-cv-00689-CFC) Joint STIPULATION TO EXTEND TIME to submit Joint Claim Construction Chart and Intrinsic Evidence to March 13, 2019 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/8/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Mar 7, 2019 | 65 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to submit Joint Claim Construction Chart and Intrinsic Evidence to March 13, 2019 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 1, 2019 | 63 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Claim Construction Intrinsic Evidence Disclosure filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 1, 2019 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Intrinsic Evidence in Support of Proposed Claim Constructions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Feb 15, 2019 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Proposed Claim Constructions for Claim Term(s)/Phrase(s) Identified by the Parties filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Feb 15, 2019 | 62 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Claim Construction Disclosure filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Feb 12, 2019 | 59 | Protective Order (28) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 2/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Feb 12, 2019 | 60 | Main Document (4) Docket Text: REDACTED VERSION of (60 in 1:18-cv-00689-CFC, 56 in 1:18-cv-00690-CFC, 56 in 1:18-cv-00651-CFC) Letter to The Honorable Colm F. Connolly regarding Protective Order Dispute by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-6)(Fahnestock, Derek) |
| Feb 12, 2019 | 60 | Exhibits 1-6 (80) |
| Feb 11, 2019 | 57 | Proposed Order (28) Docket Text: PROPOSED ORDER /[Proposed] Stipulated Protective Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 11, 2019 | 58 | Redacted Document (30) Docket Text: REDACTED VERSION of (55 in 1:18-cv-00690-CFC, 55 in 1:18-cv-00651-CFC, 58 in 1:18-cv-00689-CFC) Letter by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 7, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 2/7/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Feb 1, 2019 | 54 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of a Letter to All Defendants Regarding Claim Terms to be Construed filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 30, 2019 | 53 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Vanda Pharamceuticals Inc.'s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 25, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Concerning U.S. Patent No. 10,071,977 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jan 4, 2019 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-98) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jan 4, 2019 | 51 | Answer to Counterclaim (9) Docket Text: ANSWER to [46] Answer to Amended Complaint,, Counterclaim, / Plaintiff's Answer to Defendant's Counterclaims by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 28, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 2/7/2019 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 21, 2018 | 46 | Answer to Amended Complaint (29) Docket Text: ANSWER to Amended Complaint, re: [41] Amended Complaint [TEVA PHARMACEUTICALS USA, INC.'S ANSWER TO THE FIRST AMENDED COMPLAINT AND COUNTERCLAIMS], COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 21, 2018 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva's Identification of Email Custodians filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 21, 2018 | 48 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Initial Infringement Contentions for U.S. Patent No. 10, 071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 21, 2018 | 49 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of E-mail Custodians filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 19, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (46 in 1:18-cv-00690-CFC, 50 in 1:18-cv-00689-CFC, 45 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Submit Protective Order to December 27, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 12/19/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Dec 18, 2018 | 45 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Protective Order to December 27, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (45 in 1:18-cv-00690-CFC, 49 in 1:18-cv-00689-CFC, 44 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Identify E-Mail Custodians to December 21, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 12/13/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Dec 12, 2018 | 44 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Identify E-Mail Custodians to December 21, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 11, 2018 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (nmf) |
| Dec 11, 2018 | 40 | Order (5) Docket Text: ORDER approving JOINT STIPULATION TO AMEND COMPLAINT (43 in 1:18-cv-00689-CFC), (39 in 1:18-cv-00690-CFC), (38 in 1:18-cv-00651-CFC). Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 11, 2018 | 41 | Main Document (40) Docket Text: AMENDED COMPLAINT against Teva Pharmaceuticals USA, Inc.- filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibits 1A-G)(nmf) |
| Dec 11, 2018 | 41 | Exhibits 1A-G (252) |
| Dec 11, 2018 | 42 | Scheduling Order (5) Docket Text: AMENDED SCHEDULING ORDER re: Stipulation: Fact Discovery completed by 11/15/2019. Expert Discovery due by 4/24/2020. A Markman Hearing is set for 10/10/2019 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 9/24/2020 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/5/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 11, 2018 | 43 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,604 ;9,060,995 ;9,539,234 ;9,549,913 ;9,730,910 ;9,855,241 ;10,071,977 Adding 10,071,977 by Amended Complaint. (Fahnestock, Derek) |
| Dec 11, 2018 | 41 | Amended Complaint* (1) |
| Dec 7, 2018 | 38 | Main Document (5) Docket Text: Joint STIPULATION to Amend Complaint re [1] Complaint, by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1 - Teva Amended Complaint, # (2) Exhibit 1A-G, # (3) Exhibit 2- Apotex Amended Complaint, # (4) Exhibit 2A-G, # (5) Exhibit 3 - MSN Amended Complaint, # (6) Exhibit 3A-G)(Fahnestock, Derek) |
| Dec 7, 2018 | 38 | Exhibit 1 - Teva Amended Complaint (41) |
| Dec 7, 2018 | 38 | Exhibit 1A-G (252) |
| Dec 7, 2018 | 38 | Exhibit 2- Apotex Amended Complaint (45) |
| Dec 7, 2018 | 38 | Exhibit 2A-G (252) |
| Dec 7, 2018 | 38 | Exhibit 3 - MSN Amended Complaint (45) |
| Dec 7, 2018 | 38 | Exhibit 3A-G (252) |
| Dec 7, 2018 | 39 | Stipulation (5) Docket Text: Joint STIPULATION Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 5, 2018 | 37 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's First Set of Requests for Production of Documents and Things filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 3, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (37 in 1:18-cv-00690-CFC, 36 in 1:18-cv-00651-CFC, 41 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to December 18, 2018 filed by Vanda Pharmaceuticals Inc.. Signed by Judge Colm F. Connolly on 12/3/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Dec 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William H. Milliken, John C. Rozendaal, and Deirdre M. Wells for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Nov 30, 2018 | 36 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to December 18, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 27, 2018 | 35 | SO ORDERED (5) Docket Text: SO ORDERED, re (35 in 1:18-cv-00690-CFC, 34 in 1:18-cv-00651-CFC, 39 in 1:18-cv-00689-CFC) Stipulation and Order on E-Mail Discovery. Signed by Judge Colm F. Connolly on 11/27/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 21, 2018 | 34 | Stipulation (5) Docket Text: STIPULATION on E-Mail Discovery by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 20, 2018 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (37 in 1:18-cv-00689-CFC, 32 in 1:18-cv-00651-CFC, 33 in 1:18-cv-00690-CFC) STIPULATION TO EXTEND TIME for the parties to submit a stipulation related to electronic discovery to November 23, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/13/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 9, 2018 | 32 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a stipulation related to electronic discovery to November 23, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 2, 2018 | 31 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 12/3/2018 at 11:45 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 11/2/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(dlb) |
| Nov 1, 2018 | N/A | Remark (0) Docket Text: Remark: The docket text of the scheduling order has been updated to include the notation that the Judge made revisions to paragraph 8 and also to include the Joint Claim Construction Brief deadline to the text of the entry. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Nov 1, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(cak) |
| Nov 1, 2018 | 30 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/28/2019. Amended Pleadings due by 2/28/2019. Fact Discovery completed by 8/2/2019. Joint Claim Construction Brief due by 4/17/2019. A Markman Hearing is set for 5/20/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 5/28/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/15/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. See revisions to paragraph 8. Signed by Judge Colm F. Connolly on 10/31/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (30 in 1:18-cv-00690-CFC, 34 in 1:18-cv-00689-CFC, 29 in 1:18-cv-00651-CFC) Joint STIPULATION TO EXTEND TIME to submit a Stipulation relating to Electronic Discovery to November 9, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/26/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Oct 25, 2018 | 29 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Stipulation relating to Electronic Discovery to November 9, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 23, 2018 | 28 | Main Document (11) Docket Text: PROPOSED ORDER /Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
| Oct 23, 2018 | 28 | Cover Letter (1) |
| Oct 17, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 10/17/2018. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the Court. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 15, 2018 | 27 | Main Document (11) Docket Text: PROPOSED ORDER /Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover letter)(Fahnestock, Derek) |
| Oct 15, 2018 | 27 | Cover letter (1) |
| Oct 12, 2018 | N/A | Set/Reset Deadlines (0) Docket Text: Reset Deadline per D.I. [26]: Thirty Month Stay Deadline: 7/31/2021. In the future, counsel should file this form using the code ANDA Form, found under OTHER FILINGS, OTHER DOCUMENTS. (fms) |
| Oct 12, 2018 | 26 | Statement (3) Docket Text: STATEMENT re [3] ANDA Form, [Corrected Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA)] by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] Joint STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 25, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/11/2018. (fms) |
| Oct 10, 2018 | 25 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 25, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 4, 2018 | 24 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Sep 28, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (24 in 1:18-cv-00690-CFC, 27 in 1:18-cv-00689-CFC, 23 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 11, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 9/28/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Sep 27, 2018 | 23 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 11, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Sep 26, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference is rescheduled per request of counsel for 10/17/2018 at 10:00 AM in Chambers before Judge Colm F. Connolly Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 24, 2018 | 22 | Status Report (7) Docket Text: Joint STATUS REPORT by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Sep 20, 2018 | 21 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 10/16/2018 at 02:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/20/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 11, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Case Management Conference set for 9/17/18 before Judge Burke has been cancelled in light of the case no longer being referred. Ordered by Judge Christopher J. Burke on 9/11/2018. Associated Cases: 1:18-cv-00689-CFC, 1:18-cv-00651-CFC, 1:18-cv-00690-CFC(dlb) |
| Sep 10, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER by Judge Colm F. Connolly on 9/10/2018: In light of the reassignment of these cases, the Court HEREBY ORDERS that the prior referral to Magistrate Judge Christopher J. Burke is withdrawn, with the exception that any referral to Judge Burke for ADR shall remain in place. Associated Cases: 1:18-cv-00651-CFC-CJB, 1:18-cv-00689-CFC-CJB, 1:18-cv-00690-CFC-CJB(nmf) |
| Sep 10, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before September 24, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status Report due by 9/24/2018.) Ordered by Judge Connolly 9/10/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 6, 2018 | 20 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Identification of Accused Products and Asserted Patents and (2) Production of File Histories filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00651-CFC-CJB, 1:18-cv-00689-CFC-CJB, 1:18-cv-00690-CFC-CJB (rjb) |
| Aug 28, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: Oral Order Resetting Telephonic Scheduling Conference: At the request of counsel, the Case Management/Scheduling Conference set for 9/10/2018 has been reset for 9/17/2018 at 02:00 PM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 8/28/2018. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Aug 28, 2018 | 18 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Vanda Pharmaceuticals Inc.s Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 28, 2018 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Rule 26 Initial Disclosures (2) Defendant's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Aug 27, 2018 | 17 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Derek J. Fahnestock regarding Rescheduling Scheduling Teleconference - re Order Setting Scheduling Conference, Order Setting Scheduling Conference,. (Fahnestock, Derek) |
| Aug 22, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: Oral Order Setting Telephonic Case Management/Scheduling Conference: A Case Management/Scheduling Conference is set for 9/10/2018 at 02:00 PM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 8/22/2018. (dlb) |
| Aug 22, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order setting the Case Management/Scheduling Conference has been changed to reflect correct the date. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Aug 15, 2018 | 15 | Letter (8) Docket Text: Letter to The Honorable Christopher J. Burke from Derek J. Fahnestock regarding Case Management Issues. (Fahnestock, Derek) |
| Aug 15, 2018 | 16 | Main Document (15) Docket Text: PROPOSED ORDER /Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover letter)(Fahnestock, Derek) |
| Aug 15, 2018 | 16 | Cover letter (1) |
| Aug 13, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel J. Klein for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Josephine Young for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB(crb) |
| Aug 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer R. Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB(crb) |
| Aug 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas Groombridge for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB(crb) |
| Aug 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric A. Stone,Kira A. Davis for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB(crb) |
| Aug 3, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney Jennifer Rea Deneault of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Vanda Pharmaceuticals Inc., [8] MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young and Daniel J. Klein of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Vanda Pharmaceuticals Inc., [11] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Deirdre M. Wells, and William H. Milliken filed by Teva Pharmaceuticals USA, Inc.. Ordered by Judge Christopher J. Burke on 8/3/2018. (jcs) |
| Jul 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (13 in 1:18-cv-00651-VAC-CJB, 17 in 1:18-cv-00689-VAC-CJB, 14 in 1:18-cv-00690-VAC-CJB) STIPULATION TO EXTEND TIME re Scheduling Deadlines to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Ordered by Judge Christopher J. Burke on 7/23/2018. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Jul 23, 2018 | 14 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jennifer Rea Deneault of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Vanda Pharmaceuticals Inc.. Motions referred to Christopher J. Burke.(Jacobs, Karen) |
| Jul 20, 2018 | 13 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME re Scheduling Deadlines to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 12, 2018 | 12 | Answer to Counterclaim (8) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 21, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burkes Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (I) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order consistent with Judge Burkes Rule 16 Scheduling Order Patent; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule an in-person Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Rule 16 Scheduling Order Patent can be found on this Court's website (http://www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke). Ordered by Judge Christopher J. Burke on 6/21/2018. (dlb) |
| Jun 21, 2018 | 9 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 21, 2018 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jun 21, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Deirdre M. Wells, and William H. Milliken - filed by Teva Pharmaceuticals USA, Inc.. Motions referred to Christopher J. Burke.(Hoeschen, Nathan) |
| May 14, 2018 | 8 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young and Daniel J. Klein of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Vanda Pharmaceuticals Inc.. Motions referred to Christopher J. Burke.(Jacobs, Karen) |
| May 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [7] STIPULATION TO EXTEND TIME to Respond to the Complaint to June 21, 2018 filed by Teva Pharmaceuticals USA, Inc. Ordered by Judge Christopher J. Burke on 5/9/2018. (dlb) |
| May 9, 2018 | N/A | Set/Reset Deadlines (0) Docket Text: Reset Deadlines: Thirty Month Stay Deadline: 9/23/2020. (fms) |
| May 9, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The ANDA form at D.I. [3] has been removed and replaced per request of filer. The docket text and deadlines have been corrected. (fms) |
| May 8, 2018 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to June 21, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| May 2, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| May 2, 2018 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb) |
| May 2, 2018 | N/A | Remark (0) Docket Text: REMARK: If the parties jointly consent to have a Magistrate Judge conduct all proceedings in this case, including trial, then when Judge Burke enters a case schedule he will enter the respective pre-trial conference and trial dates onto his calendar and will honor them. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued on May 26, 2017 and available on the District Court's website), then upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be considered ready for reassignment to a visiting District Judge. Whether the pre-trial conference and trial dates will stand after reassignment will depend on the availability of those dates on the visiting District Judge's calendar. (dlb) |
| May 2, 2018 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf (dlb) |
| May 1, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 5/1/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| May 1, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/23/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/23/2020. (nmg) (Main Document 3 replaced on 5/9/2018) (fms). Modified on 5/9/2018 (fms). |
| May 1, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 5/1/2018, answer due 5/22/2018. (Jacobs, Karen) |
| Apr 30, 2018 | 1 | Main Document (33) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2372561.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(nmg) |
| Apr 30, 2018 | 1 | Exhibit A-F (241) |
| Apr 30, 2018 | 1 | Civil Cover Sheet (1) |
| Apr 30, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Apr 30, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,604 ;9,060,995 ;9,539,234 ;9,549,913 ;9,730,910 ;9,855,241. (nmg) |
| Apr 30, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vanda Pharmaceuticals Inc. (nmg) |
| Apr 30, 2018 | 1 | Complaint* (1) |
